127 related articles for article (PubMed ID: 33112676)
1. The Relationship Between Counseling and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Enrolled in Option B.
Nutor JJ; Slaughter-Acey JC; Afulani PA; Obimbo MM; Mojola SA
AIDS Educ Prev; 2020 Oct; 32(5):378-391. PubMed ID: 33112676
[TBL] [Abstract][Full Text] [Related]
2. Influence of toilet access on antiretroviral adherence intention among pregnant and breastfeeding women who are HIV-positive and enrolled in Option B.
Nutor JJ; Slaughter-Acey JC; Marquez SP; DiMaria-Ghalili RA; Momplaisir F; Jemmott LS
Health Care Women Int; 2021 Mar; 42(3):261-275. PubMed ID: 32238109
[TBL] [Abstract][Full Text] [Related]
3. Impact of attitudes and beliefs on antiretroviral treatment adherence intention among HIV-positive pregnant and breastfeeding women in Zambia.
Nutor JJ; Slaughter-Acey JC; Marquez SP; DiMaria-Ghalili RA; Momplaisir F; Oladimeji KE; Jemmott LS
BMC Public Health; 2020 Sep; 20(1):1410. PubMed ID: 32938415
[TBL] [Abstract][Full Text] [Related]
4. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
[TBL] [Abstract][Full Text] [Related]
5. Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia.
Chi BH; Mutale W; Winston J; Phiri W; Price JT; Mwiche A; Ayles H; Stringer JSA
Pediatr Infect Dis J; 2018 Nov; 37(11):1137-1141. PubMed ID: 29601456
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
[TBL] [Abstract][Full Text] [Related]
7. Adherence to antiretroviral therapy among HIV infected pregnant women in public health sectors: a pilot of Chilenje level one Hospital Lusaka, Zambia.
Mukosha M; Chiyesu G; Vwalika B
Pan Afr Med J; 2020; 35():49. PubMed ID: 32537054
[TBL] [Abstract][Full Text] [Related]
8. Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV.
Omonaiye O; Kusljic S; Nicholson P; Mohebbi M; Manias E
Int J Infect Dis; 2019 Apr; 81():225-230. PubMed ID: 30790723
[TBL] [Abstract][Full Text] [Related]
9. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
[TBL] [Abstract][Full Text] [Related]
10. Levels of option B+ ART drugs adherence and associated factors among pregnant women following ART services at public health facilities of East Shawa Zone, Oromia, Ethiopia.
Tarekegn M; Baru A; Seme A
Sex Reprod Healthc; 2019 Dec; 22():100459. PubMed ID: 31442747
[TBL] [Abstract][Full Text] [Related]
11. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
[TBL] [Abstract][Full Text] [Related]
12. Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.
Wesevich A; Hosseinipour MC; Golin CE; McGrath N; Tsidya M; Chimndozi L; Bhushan N; Hoffman I; Miller WC; Rosenberg NE
AIDS Care; 2020 Feb; 32(2):170-174. PubMed ID: 31238717
[TBL] [Abstract][Full Text] [Related]
13. 'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings.
McLean E; Renju J; Wamoyi J; Bukenya D; Ddaaki W; Church K; Zaba B; Wringe A
Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736391
[TBL] [Abstract][Full Text] [Related]
14. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
[TBL] [Abstract][Full Text] [Related]
15. Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program.
Wesevich A; Mtande T; Saidi F; Cromwell E; Tweya H; Hosseinipour MC; Hoffman I; Miller WC; Rosenberg NE
AIDS Care; 2017 Nov; 29(11):1417-1425. PubMed ID: 28355926
[TBL] [Abstract][Full Text] [Related]
16. Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania.
Zacharius KM; Basinda N; Marwa K; Mtui EH; Kalolo A; Kapesa A
PLoS One; 2019; 14(2):e0212587. PubMed ID: 30794633
[TBL] [Abstract][Full Text] [Related]
17. Water Access and Adherence Intention Among HIV-Positive Pregnant Women and New Mothers Receiving Antiretroviral Therapy in Zambia.
Nutor JJ; Marquez S; Slaughter-Acey JC; Hoffmann TJ; DiMaria-Ghalili RA; Momplaisir F; Opong E; Jemmott LS
Front Public Health; 2022; 10():758447. PubMed ID: 35433591
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
[TBL] [Abstract][Full Text] [Related]
20. Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating 'Option B+' in the South West Region.
Atanga PN; Ndetan HT; Achidi EA; Meriki HD; Hoelscher M; Kroidl A
Trop Med Int Health; 2017 Feb; 22(2):161-170. PubMed ID: 27865052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
